topper's finally got some new material, page-58

big us rally in biotechs and drugs Biotechs like SRX are extremely undervalued by US standards and I would not be surprised if US co (like Cephalon did 2 years ago and bid 4.85 for Sirtex), try to take over Sirtex with sp near 4 year lows and making over 130% revenue growth and profits tripling from a year ago. Most likely candidates would be Pfizer up 10% today and Sanofi who both have partnerships with Sirtex.